Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of decompensated alcoholic liver cirrhosis with losartan
2005-001191-12Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of losartan in alcoholic cirrhosis, sponsored by University Hospital Odense. Primary endpoint: Prevention of decompensation in alcoholic liver cirrhosis. Started Jun 2005; status: completed.
02
Drugs
losartan
03
Conditions
alcoholic cirrhosis
Beyond the preview
Go deeper on 2005-001191-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001191-12.